Assessing the relative efficacy of new drugs: an emerging opportunity

Nat Rev Drug Discov. 2015 Jul;14(7):443-4. doi: 10.1038/nrd4664.

Abstract

The increasing availability of individual-level data from clinical trials could allow the relative efficacy of new drugs to be assessed in a robust, cost-effective and timely way.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / economics
  • Cost-Benefit Analysis / trends*
  • Drugs, Investigational / economics
  • Drugs, Investigational / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic / economics
  • Randomized Controlled Trials as Topic / trends
  • Treatment Outcome*

Substances

  • Drugs, Investigational